tirzepatide tiene efecto rebote La tirzepatida produce rebote? 😱 La respuesta es no exactament ¿Tirzepatida causa “efecto rebote” y

Some international research has raised concerns about a high risk of depression, anxiety and suicidal ideation among people with anxiety or depression who take GLP-1-type medication

That means that Lf controls excess inflammatory response (Gruden and Poklar Ulrih 2021

De aanbevolen dosering is: Startdosering: 2,5 mg n keer per week gedurende 4 weken Stap omhoog: Na 4 weken verhogen naar 5 mg per week Aanpassingen: Indien nodig, kan de dosis elke 4 weken worden verhoogd met 2,5 mg per week tot een maximale dosis van 15 mg per week

Most patients report anxiety resolving within 6-8 weeks as their body adapts to GLP-1 receptor activation